tugliflozin

Merck, Pfizer make a late — very late — arrival at the SGLT2 party for diabetes
Endpoints
Thu, 12/21/17 - 10:07 am
Merck
Pfizer
SGLT2 inhibitor
diabetes
tugliflozin